Treatment and Mapping of Impostor Phenomenon

NCT05805696 | Recruiting

• 1 other identifier: 2022-01511-01
• Study Type: interventional
• Target: 20
• Locations: 1 country
• Sites: 2

Brief Summary

The aim of this study is to evaluate persons/patients with different skin diseases or pain to evaluate whether unhealthy perfectionism, stress, anxiety, impostor phenomenon (inability to realistically assess your competence and skills) and lack of self-compassion (a positive attitude towards ourselves), have impact on symptoms, handling, and treatment regarding some dermatological diseases/pain.

Conditions

Dermatoses; Vestibulodynia; Hyperhidrosis; Pain Syndrome

Outcome Measures

Primary Outcomes (2)

• Signs of impostor

  Questionnaire regarding impostor

  At the beginning, after 12 and 24 weeks

• Signs of disease/pain

  Questionnaire regarding symptoms

  At the beginning, after 12 and 24 weeks

Study Arms (1)

Treatment for five weeks

EXPERIMENTAL

The patients will get questionnaires before and 12 weeks and 24 weeks after intervention. The intervention will last for 5 weeks.

Behavioral: Impostor tasks

Interventions

Impostor tasks BEHAVIORAL

Tasks to do every week

Treatment for five weeks

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients attending the Dept of Dermatology and Venereology
• Diagnosed with a dermatological disease

You may not qualify if:

• Age under 18
• Not able to read/speak Swedish

Sponsors & Collaborators

• Umeå University: lead

Study Sites (2)

Umea University

Umeå, 90185, Sweden

RECRUITING

Dept of Public Health and Clinical Medicine, Umeå University

Umeå, 90186, Sweden

ACTIVE NOT RECRUITING

MeSH Terms

Conditions

Skin Diseases; Vulvodynia; Hyperhidrosis; Somatoform Disorders

Condition Hierarchy (Ancestors)

Skin and Connective Tissue Diseases; Vulvar Diseases; Genital Diseases, Female; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Genital Diseases; Sweat Gland Diseases; Mental Disorders

Central Study Contacts

Elisabet Nylander, MD, PhD

CONTACT

+46907859191; elisabet.nylander@umu.se

Jens Boman, MD, PhD

CONTACT

+46907851111; jens.boman@umu.se

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Masking Details: The participants will get a code to use for all questionnaires. The questionnaires and the intervention messages will be handled by a person that will not be involved in the answers. The questionnaires will be answered on-line with a code and handled by a person not former involved and thus completely unaware of which patients are attending.
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor/senior consultant

Model Details: All patients will get the same questionnaires and the same intervention

Study Record Dates

• First Submitted: March 9, 2023
• First Posted: April 10, 2023
• Study Start: May 15, 2024
• Primary Completion: December 31, 2024
• Study Completion: December 31, 2024
• Last Updated: May 10, 2024

Record last verified: 2024-05

Data Sharing

• IPD Sharing: Will not share

Locations

SE (2)